Interviews with innovators at the intersections of science, data, and technology.
…
continue reading
1
Leslie Loveless of Slone Partners
26:56
26:56
เล่นในภายหลัง
เล่นในภายหลัง
ลิสต์
ถูกใจ
ที่ถูกใจแล้ว
26:56
Leslie brings nearly 20 years of healthcare industry and executive search experience to Slone Partners. She joined the firm in 2007, became Chief Operating Officer in 2014 and CEO in 2016.At Slone Partners, Leslie acts as the leader of the organization as well as the head of the Executive Search team. Her involvement with clients and candidates ena…
…
continue reading
1
Andy Scharenberg of Casebia Therapeutics
29:27
29:27
เล่นในภายหลัง
เล่นในภายหลัง
ลิสต์
ถูกใจ
ที่ถูกใจแล้ว
29:27
Andy Scharenberg is Chief Scientific Officer at Casebia. Before joining Casebia, Scharenberg was an attending physician at Seattle Children’s Hospital and Principal Investigator in the Center for Immunity and Immunotherapies at Seattle Children’s Research Institute. In addition, he served as Co-Director of the Program for Cell and Gene Therapy at S…
…
continue reading
Dr. Michael Johnson is a 2017 and 2019 Forbes 30 Under 30 honoree and the CEO and Co-Founder of Visikol Inc., which is a bio-imaging company that spun out of Rutgers University in 2016 and that Michael founded along with his fellow Ph.D. candidate Thomas Villani and colleague Nick Crider. Michael has a diverse background with experiences in both th…
…
continue reading
1
Arvind Nallakkan of Five Prime Therapeutics
28:26
28:26
เล่นในภายหลัง
เล่นในภายหลัง
ลิสต์
ถูกใจ
ที่ถูกใจแล้ว
28:26
Arvind joined Five Prime Therapeutics in 2009 and currently serves as Senior Vice President, Strategic Technology Operations. He is responsible for Systems Engineering (Robotic Automation & Automated Data Integration), Information Technology, Process Development, Manufacturing, and Supply Chain functions. Technology innovations at Five Prime includ…
…
continue reading
1
Fiona Nielsen of Repositive
21:42
21:42
เล่นในภายหลัง
เล่นในภายหลัง
ลิสต์
ถูกใจ
ที่ถูกใจแล้ว
21:42
Fiona is a bioinformatics scientist turned entrepreneur. Having worked at Illumina developing tools for interpretation of next-generation sequencing data and analyzing cancer genomes, she realized the main bottleneck for genome interpretation and precision medicine is accessing the right data, and so decided to disrupt outdated practices with the a…
…
continue reading